Glenmark launches digital dose inhaler for asthma patients – Financial Express


Financial Express

Glenmark launches digital dose inhaler for asthma patients
Financial Express
“This next-gen inhaler provides accurate digital dose counter along with low dose warning indicator to enable Asthma and chronic obstructive pulmonary disease (COPD) patients to track adherence to their therapy,” the Mumbai-based firm said in a statement.
Glenmark launches electronic inhaler for asthma patientsHindu Business Line
Glenmark launches measurable inhaler for asthma, COPD patientsBusiness Standard

all 5 news articles »

View full post on asthma – Google News

Sun Pharma launches mobile app for asthma patients – Financial Express


ETCIO.com

Sun Pharma launches mobile app for asthma patients
Financial Express
As part of its focus to give boost to treatment compliance amongst Asthma patients by minimising instances of non-adherence and drop-outs in Asthma treatment regime, Sun Pharma Sun Pharma is rolling out India's first unique and innovative mobile …
Sun Pharma's RespiTrack mobile app to boost treatment compliance amongst asthma patientsETCIO.com
Sun Pharma takes mobile app route to raise disease awareness: Abhay GandhiBusiness Standard

all 3 news articles »

View full post on asthma – Google News

Programs address cardiovascular disease, immunization, asthma and reducing … – The FINANCIAL

Programs address cardiovascular disease, immunization, asthma and reducing
The FINANCIAL
Each pilot program addresses a region-specific health issue such as heart disease and diabetes, childhood immunization, asthma and respiratory disease management, and patient compliance and retention. “GE recognizes there is a critical need in the U.S.

and more »

View full post on asthma – Google News

Halozyme Therapeutics Reports Third Quarter 2011 Financial Results – PR Newswire (press release)

Halozyme Therapeutics Reports Third Quarter 2011 Financial Results
PR Newswire (press release)
Baxter presented its Phase III data for the HyQ program at the American College of Allergy, Asthma & Immunology. HyQ was shown to be effective in subjects with Primary Immunodeficiency and enabled 94% of subjects to receive full 3 or 4-weekly doses of
Baxter Presents Phase III HyQ Efficacy and Tolerability Data at American MarketWatch (press release)

all 27 news articles »

View full post on asthma – Google News

Asthma Relief provided by new electrostatic air filters – Middle East North Africa Financial Network

Asthma Relief provided by new electrostatic air filters
Middle East North Africa Financial Network
ACI Manufacturing has improved the "ULTRA" washable electrostatic furnace filters allowing the millions of Americans that suffer from asthma related symptoms a little relief. Two improvements have been made to the electrostatic furnace filters.

View full post on asthma – Google News